T2	Participants 193 240	patients receiving long-term dialysis treatment
T3	Participants 377 421	patients with end-stage renal disease (ESRD)
T1	Participants 582 611	in Chinese patients with ESRD
T4	Participants 2333 2397	finding supports the results of previous US and European studies
